Search Orphan Drug Designations and Approvals
-
Generic Name: | IgG1 antibody directed against the extra domain-B splice variant of fibronectin and conjugated to auristatin |
---|---|
Date Designated: | 05/03/2023 |
Orphan Designation: | Treatment of pancreatic cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Pyxis Oncology 321 Harrison Avenue, Floor 11, Suite 1 Boston, Massachusetts 02118 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-